Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochemical and biophysical research communications. 1965;18(2):221–5.
2. Nguyen Y, Stirnemann J, Belmatoug N. Gaucher disease: a review. La Revue de medecine interne. 2019;40(5):313–22.
3. Maas M, Poll L, Terk M. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol. 2002;75(Suppl 1):A13-24.
4. Lebel E, Itzchaki M, Elstein D, Hadas-Halpern I, Abrahamov A, Zimran A. Skeletal manifestations in Gaucher disease: presentation and treatment. The Israel Medical Association journal: IMAJ. 1999;1(4):267–71.
5. Lai JK, Robertson PL, Goh C, Szer J. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience. Blood Cells, Molecules, and Diseases. 2018;68:121–5.